Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?

Mitochondrial abnormalities have been identified as a central mechanism in multiple neurodegenerative diseases and, therefore, the mitochondria have been explored as a therapeutic target. This review will focus on the evidence for mitochondrial abnormalities in the two most common neurodegenerative...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical Society transactions Vol. 46; no. 4; p. 891
Main Authors: Macdonald, Ruby, Barnes, Katy, Hastings, Christopher, Mortiboys, Heather
Format: Journal Article
Language:English
Published: England 20.08.2018
Subjects:
Alzheimer Disease - drug therapy
Alzheimer Disease - genetics
Alzheimer Disease - metabolism
Alzheimer Disease - pathology
Animals
Antioxidants - metabolism
Antioxidants - pharmacology
Drug Delivery Systems
Humans
Mitochondria - drug effects
Mitochondria - metabolism
Mitochondrial Dynamics
Mitochondrial Proteins - metabolism
Models, Biological
Neuroprotective Agents - pharmacology
Neuroprotective Agents - therapeutic use
Parkinson Disease - drug therapy
Parkinson Disease - metabolism
Parkinson Disease - pathology
therapeutics
mitochondrial dysfunction
Parkinson's disease
Alzheimer's disease
ISSN:1470-8752, 1470-8752
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mitochondrial abnormalities have been identified as a central mechanism in multiple neurodegenerative diseases and, therefore, the mitochondria have been explored as a therapeutic target. This review will focus on the evidence for mitochondrial abnormalities in the two most common neurodegenerative diseases, Parkinson's disease and Alzheimer's disease. In addition, we discuss the main strategies which have been explored in these diseases to target the mitochondria for therapeutic purposes, focusing on mitochondrially targeted antioxidants, peptides, modulators of mitochondrial dynamics and phenotypic screening outcomes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1470-8752
1470-8752
DOI:10.1042/BST20170501